Revenue
2019
2020
2021
2022
2023
2024
Medirom Healthcare Technologies Inc. (MRM)
Price$0.9200Cached quote
Net income
2019
2020
2021
2022
2023
2024
Free cash flow
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue | ¥8.30B | ¥6.83B | ¥6.95B | ¥5.41B | ¥3.34B | ¥3.91B |
| Gross profit | ¥2.25B | ¥1.57B | ¥1.90B | ¥1.42B | — | — |
| Gross margin | 27.07% | 22.98% | 27.36% | 26.16% | — | — |
| Operating expenses | ¥8.32B | ¥7.22B | ¥6.86B | ¥5.88B | ¥4.09B | ¥3.87B |
| Operating income | −¥18.1M | −¥391.6M | ¥97.0M | −¥470.6M | −¥746.1M | ¥34.4M |
| Operating margin | −0.22% | −5.73% | 1.39% | −8.70% | −22.33% | 0.88% |
| EBITDA | ¥271.9M | −¥139.0M | ¥281.0M | −¥344.3M | −¥683.8M | ¥80.5M |
| EBITDA margin | 3.28% | −2.04% | 4.04% | −6.37% | −20.46% | 2.06% |
| Net income | ¥148.8M | ¥115.4M | ¥149.0M | −¥990.7M | −¥539.2M | ¥17.3M |
| Net profit margin | 1.79% | 1.69% | 2.14% | −18.31% | −16.14% | 0.44% |
| Basic EPSper basic share | ¥29.13 | ¥23.64 | ¥30.54 | -¥203.13 | -¥133.97 | ¥4.63 |
| Diluted EPSper diluted share | ¥28.52 | ¥22.34 | ¥27.23 | -¥203.13 | -¥133.97 | ¥4.06 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Eguchi Kouji | 1.93M |
CITADEL ADVISORS LLC | 56.1K |
HRT FINANCIAL LP | 54.76K |
Fujiwara Fumitoshi | 40K |
Uekusa Yoshio | 28.84K |
Ogawa Tomoya | 28.5K |
UBS Group AG | 27.18K |
Virtu Financial LLC | 15.79K |
TWO SIGMA SECURITIES, LLC | 10.57K |
GAMMA Investing LLC | 3.8K |
RHUMBLINE ADVISERS | 3.1K |
Nojima Akira | 1.2K |
Arax Advisory Partners | 300 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data